🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/09/2004 | 38,25 | 39,49 | 37,47 | 39,04 | +2,56% | 5,28% | 150.415 |
| 01/09/2004 | 36,91 | 38,74 | 36,38 | 38,07 | +3,46% | 6,39% | 466.099 |
| 31/08/2004 | 36,27 | 37,28 | 35,56 | 36,79 | +1,34% | 4,75% | 228.027 |
| 30/08/2004 | 38,55 | 38,55 | 36,16 | 36,31 | -5,18% | 6,21% | 136.308 |
| 27/08/2004 | 37,32 | 38,29 | 37,32 | 38,29 | +1,79% | 2,61% | 280.044 |
| 26/08/2004 | 37,88 | 38,55 | 37,13 | 37,62 | -0,69% | 3,75% | 162.998 |
| 25/08/2004 | 37,21 | 38,33 | 36,31 | 37,88 | +1,50% | 5,43% | 201.310 |
| 24/08/2004 | 35,75 | 37,32 | 35,48 | 37,32 | +5,17% | 5,13% | 486.858 |
| 23/08/2004 | 37,47 | 37,99 | 34,73 | 35,48 | -3,56% | 8,69% | 426.799 |
| 20/08/2004 | 34,02 | 37,43 | 34,02 | 36,79 | +6,73% | 10,01% | 429.070 |
| 19/08/2004 | 34,25 | 35,37 | 33,69 | 34,47 | +1,10% | 4,92% | 326.130 |
| 18/08/2004 | 33,50 | 34,40 | 33,09 | 34,10 | +2,02% | 3,91% | 472.084 |
| 17/08/2004 | 33,69 | 34,06 | 32,94 | 33,42 | -0,78% | 3,33% | 385.094 |
| 16/08/2004 | 31,93 | 34,55 | 31,59 | 33,69 | +5,02% | 9,26% | 349.427 |
| 13/08/2004 | 33,54 | 33,57 | 32,08 | 32,08 | -4,14% | 4,46% | 214.134 |
| 12/08/2004 | 34,25 | 34,59 | 33,31 | 33,46 | -2,30% | 3,72% | 244.805 |
| 11/08/2004 | 30,36 | 34,47 | 30,21 | 34,25 | +10,64% | 14,06% | 920.924 |
| 10/08/2004 | 29,76 | 31,10 | 29,49 | 30,95 | +1,85% | 5,41% | 387.285 |
| 09/08/2004 | 30,51 | 31,14 | 29,72 | 30,39 | +0,87% | 4,66% | 503.983 |
| 06/08/2004 | 28,52 | 30,47 | 27,74 | 30,13 | +2,42% | 9,58% | 959.529 |
| 05/08/2004 | 29,49 | 29,94 | 28,60 | 29,42 | -1,63% | 4,57% | 3.225.156 |
| 04/08/2004 | 31,55 | 32,56 | 28,30 | 29,91 | -2,32% | 13,52% | 2.404.740 |
| 03/08/2004 | 38,70 | 38,93 | 30,47 | 30,62 | -39,76% | 21,86% | 7.781.844 |
| 02/08/2004 | 51,95 | 51,95 | 49,63 | 50,83 | -1,67% | 4,47% | 212.772 |
| 30/07/2004 | 50,87 | 52,59 | 50,79 | 51,69 | +1,25% | 3,53% | 165.991 |
| 29/07/2004 | 50,61 | 51,17 | 49,03 | 51,05 | +1,34% | 4,22% | 173.445 |
| 28/07/2004 | 50,94 | 51,43 | 48,51 | 50,38 | -1,39% | 5,73% | 243.603 |
| 27/07/2004 | 48,81 | 51,62 | 48,81 | 51,09 | +4,92% | 5,75% | 387.098 |
| 26/07/2004 | 50,16 | 51,58 | 48,47 | 48,70 | -1,59% | 6,19% | 283.571 |
| 23/07/2004 | 50,83 | 51,32 | 49,41 | 49,48 | -2,87% | 3,76% | 138.152 |